Behavioral and Neural Target Engagement for ADHD Executive Working Memory Training
| Registry | NCT04795674 |
|---|---|
| Status | Completed |
| Phase | Not applicable |
| Study type | Interventional; randomized, parallel, masking: single, treatment |
| Enrollment | 62 (Actual) |
| Sponsor | Hartford Hospital (Other) |
| Conditions | ADHD |
| Interventions | EWM Training, Placebo Training (Behavioral) |
| Dates | start 2021-11-01, primary completion 2023-03-19, completion 2023-03-19, first posted 2021-03-12, last updated 2023-08-02 |
| Locations | 1 site in United States |
Related Papers Related Patents Related Grants Related Experts
AI Assistant Save
All trials for ADHD All trials of EWM Training All trials of Placebo Training
This study will assess whether or not a novel executive working memory training intervention for Attention-Deficit/Hyperactivity Disorder can engage frontoparietal brain network treatment targets and behavioral performance.
This proposal seeks support for a 2-year milestone-driven R61 initial test of target engagement in n=62 ADHD diagnosed adolescents randomized to a 'sham training' placebo or to train 4 times each week using 4 different EWM exercises that have been combined into the format of a typical cognitive training intervention. Exercise difficulty levels in the active intervention will increase across 5 weeks to continually challenge EWM ability. EWM training will use a novel, remotely-supervised 'at home' computerized training approach. If R61 EWM training target engagement milestones are met, a 3-year R33 phase will begin. The R33 will replicate target engagement in another randomized placebo-controlled trial of n=90 new ADHD adolescents and attempt to establish a convincing link between the hypothesized targets and ADHD symptom expression. It also will characterize ADHD brain activity or EWM ability changes relative to typical levels seen in an n=40 non-ADHD control group.
| Arm | Type | Interventions | Description |
|---|---|---|---|
| ADHD EWM | Experimental | Behavioral: EWM Training | Participants will receive EWM training sessions. |
| ADHD Placebo | Placebo comparator | Behavioral: Placebo Training | Participants will receive placebo training sessions. |
Sex: All, ages: 12 Years to 18 Years
Inclusion Criteria: * Diagnosis of ADHD * English speaking * Right-handed * >5th grade reading level * >80 IQ level Exclusion Criteria: * Braces, metal or implant devices * Brain abnormality, neurological disorder * TBI or loss of consciousness>30 minutes * Diagnosis of Psychosis, Bipolar Disorder, ASD, PTSD, OCD, SUD, Tourette's Disorder
| Facility | City | Country | Status |
|---|---|---|---|
| Institute of Living/Hartford Hospital | Hartford, Connecticut | United States |